# Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

> **NCT06694792** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 800 (estimated)

## Conditions studied

- IPMN, Pancreatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06694792
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06694792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06694792, "Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06694792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*